These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23081956)

  • 1. In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T.
    Walker P; Provent P; Tizon X; Créhange G; Duchamp O; Brunotte F; Genne P
    Acta Radiol; 2013 Feb; 54(1):121-6. PubMed ID: 23081956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy.
    Kiessling F; Huber PE; Grobholz R; Heilmann M; Meding J; Lichy MP; Fink C; Krix M; Peschke P; Schlemmer HP
    Invest Radiol; 2004 Jan; 39(1):34-44. PubMed ID: 14701987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic and metabolic characterization of orthotopic rat prostate carcinomas using dynamic MRI and proton magnetic resonance spectroscopy].
    Kiessling F; Lichy M; Grobholz R; Heilmann M; Huber PE; Meding J; Peschke P; Kauczor HU; Schlemmer HP
    Radiologe; 2003 Jun; 43(6):489-94. PubMed ID: 12827264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-voxel magnetic resonance spectroscopy of cerebral metabolites in healthy adults at 3 Tesla.
    Doelken MT; Mennecke A; Stadlbauer A; Kloska S; Struffert T; Engelhorn T; Thuerauf N; Doerfler A; Stefan H; Hammen T
    Acad Radiol; 2009 Dec; 16(12):1493-501. PubMed ID: 19781961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging.
    Dyke JP; Zakian KL; Spees WM; Matei C; Chen Y; Mao X; Shungu DC; Koutcher JA
    Clin Cancer Res; 2003 Oct; 9(12):4529-36. PubMed ID: 14555527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1H magnetic resonance spectroscopy of the prostate].
    Mueller-Lisse UG; Scherr M
    Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
    Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y
    Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.
    Crehange G; Maingon P; Gauthier M; Parfait S; Cochet A; Mirjolet C; Bonnetain F; Cormier L; Brunotte F; Walker P
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e407-13. PubMed ID: 21605949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of myo-inositol metabolic level in the left dorsolateral prefrontal cortex of rats exposed to forced swimming test following desipramine treatment: an in vivo localized (1)H-MRS study at 4.7 T.
    Kim SY; Choi CB; Lee HS; Lee SH; Woo DC; Kim HY; Hong KS; Lee CH; Choe BY
    Magn Reson Imaging; 2010 Dec; 28(10):1461-7. PubMed ID: 20817439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
    Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
    NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study.
    Reyngoudt H; Claeys T; Vlerick L; Verleden S; Acou M; Deblaere K; De Deene Y; Audenaert K; Goethals I; Achten E
    Eur J Radiol; 2012 Mar; 81(3):e223-31. PubMed ID: 21345628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
    Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
    J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
    Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
    Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer.
    Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S
    Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
    Kirilova A; Damyanovich A; Crook J; Jezioranski J; Wallace K; Pintilie M
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):371-8. PubMed ID: 20421147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
    Tong ZY; Toshiaki Y; Wang YJ
    Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.